Immunovia AB (publ)
IMMVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -40.9% | 37.6% | 35.7% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 100% | -324.3% | -267.8% | 1,873.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6,580.6% | -9,426.2% | -12,365% | -16,051.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,221.4% | -19,646.9% | -14,680.5% | -18,479.4% |
| EPS Diluted | -0.93 | -7.95 | -6.89 | -6.4 |
| % Growth | 88.3% | -15.4% | -7.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |